CA
USNA icon

Continuum Advisory’s Usana Health Sciences USNA Stock Holding History

Continuum Advisory’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.06K Buy
+190
New +$3.57K ﹤0.01% 1530
2025
Q2 		– Sell
-190
Closed -$5.12K – 1512
2025
Q1 		$5.12K Hold
190
– – ﹤0.01% 1107
2024
Q4 		$6.82K Hold
190
– – ﹤0.01% 1073
2024
Q3 		$7.49K Buy
+190
New +$7.81K ﹤0.01% 1070

Other funds holding USNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Continuum Advisory's USNA Position: Q2 2026 in Review

Continuum Advisory opened a new position in Usana Health Sciences (USNA) in Q2 2026: 190 shares worth $4.06K. The stake represents ﹤0.01% of the portfolio and ranks #1530 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in USNA as recently as Q1 2025.

Continuum Advisory first reported a position in USNA in Q3 2024 and has held it in 4 quarters since. The position peaked at $7.49K in Q3 2024. 137 funds tracked by Wall St. Rank hold USNA as of Q2 2026.

  • Continuum Advisory held 190 shares of Usana Health Sciences worth $4.06K as of Q2 2026.
  • Usana Health Sciences was a new Continuum Advisory position in Q2 2026.
  • Usana Health Sciences made up ﹤0.01% of Continuum Advisory's portfolio in Q2 2026, its #1530 holding.
  • Continuum Advisory first reported a position in Usana Health Sciences in Q3 2024 and has held it in 4 quarters since.
  • Continuum Advisory's Usana Health Sciences position peaked at $7.49K in Q3 2024.
  • 137 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.

Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.